These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 36081760)
1. Inadvertent Transfer of Murine VL30 Retrotransposons to CAR-T Cells. Lee SH; Hao Y; Gui T; Dotti G; Savoldo B; Zou F; Kafri T Adv Cell Gene Ther; 2022; 2022():. PubMed ID: 36081760 [TBL] [Abstract][Full Text] [Related]
2. A small and efficient dimerization/packaging signal of rat VL30 RNA and its use in murine leukemia virus-VL30-derived vectors for gene transfer. Torrent C; Gabus C; Darlix JL J Virol; 1994 Feb; 68(2):661-7. PubMed ID: 8289369 [TBL] [Abstract][Full Text] [Related]
3. Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy. Chakraborty AK; Zink MA; Hodgson CP Cancer Gene Ther; 1994 Jun; 1(2):113-8. PubMed ID: 7621242 [TBL] [Abstract][Full Text] [Related]
4. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells. Patience C; Takeuchi Y; Cosset FL; Weiss RA J Virol; 1998 Apr; 72(4):2671-6. PubMed ID: 9525584 [TBL] [Abstract][Full Text] [Related]
5. An internal ribosomal entry signal in the rat VL30 region of the Harvey murine sarcoma virus leader and its use in dicistronic retroviral vectors. Berlioz C; Torrent C; Darlix JL J Virol; 1995 Oct; 69(10):6400-7. PubMed ID: 7666541 [TBL] [Abstract][Full Text] [Related]
6. Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus. Torrent C; Bordet T; Darlix JL J Mol Biol; 1994 Jul; 240(5):434-44. PubMed ID: 8046749 [TBL] [Abstract][Full Text] [Related]
7. Identification of an internal ribosome entry segment in the 5' region of the mouse VL30 retrotransposon and its use in the development of retroviral vectors. López-Lastra M; Ulrici S; Gabus C; Darlix JL J Virol; 1999 Oct; 73(10):8393-402. PubMed ID: 10482590 [TBL] [Abstract][Full Text] [Related]
8. Efficient packaging of a specific VL30 retroelement by psi 2 cells which produce MoMLV recombinant retroviruses. Hatzoglou M; Hodgson CP; Mularo F; Hanson RW Hum Gene Ther; 1990; 1(4):385-97. PubMed ID: 1964095 [TBL] [Abstract][Full Text] [Related]
9. Stable MLV-VL30 dicistronic retroviral vectors with a VL30 or MoMLV sequence promoting both packaging of genomic RNA and expression of the 3' cistron. Torrent C; Berlioz C; Darlix JL Hum Gene Ther; 1996 Mar; 7(5):603-12. PubMed ID: 8845385 [TBL] [Abstract][Full Text] [Related]
10. MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency. Patience C; Takeuch Y; Cosset FL; Weiss RA Dev Biol (Basel); 2001; 106():169-79; discussion 253-63. PubMed ID: 11761229 [TBL] [Abstract][Full Text] [Related]
11. A murine leukemia virus derived retroviral vector with a rat VL30 packaging psi sequence. Torrent C; Wang P; Darlix JL Bone Marrow Transplant; 1992; 9 Suppl 1():143-7. PubMed ID: 1324044 [TBL] [Abstract][Full Text] [Related]
12. High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia. Müller S; Bexte T; Gebel V; Kalensee F; Stolzenberg E; Hartmann J; Koehl U; Schambach A; Wels WS; Modlich U; Ullrich E Front Immunol; 2019; 10():3123. PubMed ID: 32117200 [TBL] [Abstract][Full Text] [Related]
13. Organization and expression of endogenous virus-like (VL30) DNA sequences in nontransformed and chemically transformed mouse embryo cells in culture. Courtney MG; Schmidt LJ; Getz MJ Cancer Res; 1982 Feb; 42(2):569-76. PubMed ID: 6275981 [TBL] [Abstract][Full Text] [Related]
14. Virus-like 30S RNA in mouse cells. Besmer P; Olshevsky U; Baltimore D; Dolberg D; Fan H J Virol; 1979 Mar; 29(3):1168-76. PubMed ID: 221671 [TBL] [Abstract][Full Text] [Related]
15. Retroviral-mediated transfer and expression of the multidrug resistance protein 1 gene (MRP1) protect human hematopoietic cells from antineoplastic drugs. Omori F; Juopperi T; Chan CK; Chang YN; Phipps S; Nanji S; Zhao Y; Stewart AK; Dubé ID J Hematother Stem Cell Res; 1999 Oct; 8(5):503-14. PubMed ID: 10791901 [TBL] [Abstract][Full Text] [Related]
16. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells. Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809 [TBL] [Abstract][Full Text] [Related]